Brii Biosciences Limited (HKG:2137)

Brii Biosciences Statistics

Total Valuation

HKG:2137 has a market cap or net worth of HKD 1.01 billion. The enterprise value is -1.20 billion.

Market Cap	1.01B
Enterprise Value	-1.20B

Important Dates

The last earnings date was Thursday, March 19, 2026.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2137 has 721.54 million shares outstanding. The number of shares has decreased by -1.15% in one year.

Current Share Class	721.54M
Shares Outstanding	721.54M
Shares Change (YoY)	-1.15%
Shares Change (QoQ)	-0.46%
Owned by Insiders (%)	5.02%
Owned by Institutions (%)	5.23%
Float	594.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.54
PB Ratio	0.39
P/TBV Ratio	0.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	4.83
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 60.73, with a Debt / Equity ratio of 0.00.

Current Ratio	60.73
Quick Ratio	60.02
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-146.25

Financial Efficiency

Return on equity (ROE) is -9.09% and return on invested capital (ROIC) is -7.22%.

Return on Equity (ROE)	-9.09%
Return on Assets (ROA)	-7.08%
Return on Invested Capital (ROIC)	-7.22%
Return on Capital Employed (ROCE)	-12.32%
Weighted Average Cost of Capital (WACC)	11.67%
Revenue Per Employee	527,442
Profits Per Employee	-3.30M
Employee Count	96
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:2137 has paid 2.11 million in taxes.

Income Tax	2.11M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.91% in the last 52 weeks. The beta is 1.34, so HKG:2137's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	-39.91%
50-Day Moving Average	1.50
200-Day Moving Average	1.76
Relative Strength Index (RSI)	45.13
Average Volume (20 Days)	1,200,317

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2137 had revenue of HKD 39.56 million and -247.74 million in losses. Loss per share was -0.34.

Revenue	39.56M
Gross Profit	39.56M
Operating Income	-319.16M
Pretax Income	-247.23M
Net Income	-247.74M
EBITDA	-316.66M
EBIT	-319.16M
Loss Per Share	-0.34

Balance Sheet

The company has 2.16 billion in cash and 9.94 million in debt, with a net cash position of 2.15 billion or 2.98 per share.

Cash & Cash Equivalents	2.16B
Total Debt	9.94M
Net Cash	2.15B
Net Cash Per Share	2.98
Equity (Book Value)	2.59B
Book Value Per Share	3.67
Working Capital	2.15B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	2.54M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-806.80%
Pretax Margin	-624.98%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:2137 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.15%
Shareholder Yield	1.15%
Earnings Yield	-24.52%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2